Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This study will test whether the combination of cisplatin, nivolumab, and temozolomide is an
effective treatment for in people with advanced and/or metastatic colorectal cancer that is
mismatch repair-proficient (MMR-proficient). The researchers will also look at how safe the
study drug combination is in participants.